Types of cancer

General cancer research
Why is cancer research important?

We explore why cancer research matters, how it leads to new treatments and cures, and why funding early stage discoveries is vital for a future when no life is cut short by cancer.

General cancer research
Why haven't we cured cancer yet?

We explain the reasons why cancer is especially hard to cure, but also the reasons to be optimistic for the future of cancer research.

Blood cancer
What is acute myeloid leukaemia (AML)?

AML is the most common acute leukaemia found in adults - an aggressive blood cancer that starts in the bone marrow. Find out more about its symptoms, treatment, and why research funded by our Curestarters is helping people with this aggressive type of cancer. 

Leukaemia
What is chronic myeloid leukaemia?

CML is a rare type of blood cancer with one of the greatest research success stories in modern medicine. Find out all about it and why continued research still matters to find new cures.

Brain cancer
Is there hope for diffuse midline glioma (DMG), an aggressive childhood cancer?

Diffuse midline glioma (DMG) is a particularly aggressive type of childhood brain cancer for which more research is urgently needed. But progress IS being made. Discover how you are helping families affected by this incurable cancer.

 People having a serious conversation against a yellow background
Breast cancer
Is there hope for triple negative breast cancer?

Triple negative breast cancer (TNBC) is a particularly aggressive type of breast cancer for which more research is urgently needed. But thanks to our Curestarters, progress IS being made.

Stomach cancer
What is stomach cancer?

Stomach cancer is when cancer develops and is found anywhere in the stomach. Here we answer your questions about this cancer type and how research is driving new cures. 

Bowel cancer
What is small bowel cancer?

Find out what small bowel cancer is, why it can be difficult to diagnose and how funding more of our early-stage cancer research could lead to better treatments and outcomes.